VC-Backed Danish Biotech Zealand Pharma Files $86M US IPO
Zealand Pharma, a venture capital-backed developer of diabetes treatments, filed an $86 million U.S. initial public offering on Thursday, under guidance from Dechert LLP, marking the third biotechnology company and second...To view the full article, register now.
Already a subscriber? Click here to view full article